Neuroprotective Effects of Herbal Ethanol Extracts from Gynostemma pentaphyllum on L-DOPA Therapy in 6-hydroxydopamine-lesioned Rat Model of Parkinson's Disease
![]() |
Suh, Kwang-Hoon
(College of Pharmacy, Chungbuk National University)
Choi, Hyun-Sook (College of Pharmacy, Chungbuk National University) Shin, Keon-Seong (College of Pharmacy, Chungbuk National University) Hwang, Bang-Yeon (College of Pharmacy, Chungbuk National University) Lee, Myung-Koo (College of Pharmacy, Chungbuk National University) |
1 | Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A. and Mucke, L. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287: 1265-1269. DOI |
2 | Mura, A., Mintz, M. and Feldon, J. (2002) Behavioral and anatomical effects of long-term L-dihydroxyphenylalanine (L-DOPA) administration in rats with unilateral lesions of the nigrostriatal system. Exp. Neurol. 177: 252-264. DOI ScienceOn |
3 | Shang, L., Liu, J,. Zhu, Q., Zhao, L., Feng Y., Wang, X. Cao, W. and Xin, H. (2006) Gypenosides protect primary cultures of rat cortical cells against oxidative neurotoxicity. Brain Res. 1102: 163-174. DOI ScienceOn |
4 | Wang, P., Niu, L., Gao, L., Li, W. X., Jia, D., Wang, X. L. and Gao, G. D. (2010) Neuroprotective effect of gypenosides against oxidative injury in the substantia nigra of a mouse model of Parkinson's disease. J. Int. Med. Res. 38: 1084- 1092. DOI ScienceOn |
5 | Attawish, A., Chivapat, S., Phadungpat, S., Bansiddhi, J., Techadamrongsin, Y., Mitrijit, O., Chaorai, B. and Chavalittumrong, P. (2004) Chronic toxicity of Gynostemma pentaphyllum. Fitoterapia 75: 539-551. DOI ScienceOn |
6 | Jeong, S. H., Lee, M. K., Park, M. S. and Kim, J. M. (2011) Randomized, double-blind study of efficacy and safety of Gynostemma pentaphyllum ethanol extract in a normal population. Kor. J. Clin. Pharm. 21: 131-137. |
7 | Chaturvedi, R, K., Shukla, S., Seth, K., Chauhan, S., Sinha, C., Shukla, Y. and Agrawal, A. K. (2006) Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine- lesioned rat model of Parkinson's disease. Neurobiol. Dis. 22: 421-434. DOI ScienceOn |
8 | Bae, N., Ahn, T., Chung, S., Oh, M. S., Ko, H., Oh, H., Park, G. and Yang H. O. (2010) The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson's disease. J. Ethnopharmacol. 134: 313-322. |
9 | Choi, H. S., Shin, K. S., Choi, S. O., Kim, S. H., Lee, C. K., and Lee, M. K. (2011) Ameliorating effects of herbal ethanol extract from Gynostemma pentaphyllum on chronic stressinduced anxiety in mice. Kor. J. Pharmacogn. 42: 32-37. |
10 | Choi, H. S. Park, M. S., Kim, S. H., Hwang, B. Y., Lee, C. K. and Lee, M. K. (2010). Neuroprotective effects of herbal ethanol extracts from Gynostemma pentaphyllum in the 6- hydroxydopamine-lesioned rat model of Parkinson's disease. Molecules 15: 2814-2824. DOI ScienceOn |
11 | Lee, C. S., Sauer, H. and Bjorklund, A. (1996) Dopaminergic neuronal degeneration and motor impairments following axonterminal lesion by intrastriatal 6-hydroxydopamine in rats. Neuroscience 72: 641-653. DOI ScienceOn |
12 | Borah, A. and Mohanakumar, K. P. (2009) Long term LDOPA treatment causes production of 6-OHDA in the mouse striatum: Involvement of hydroxyl radical. Ann. Neurosci. 16: 160-165. |
13 | Schober, A. (2004) Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 318: 215-224. DOI ScienceOn |
14 | Paxinos, G. and Watson, C. (1986) The rat brain in stereotaxic coordinates. 2nd ed., Academic Press, Australia. |
15 | Lee, J. J., Kim, Y. M., Yin, W. Y., Park, H. D., Kang, M. H., Hong, J. T. and Lee, M. K. (2003) Aggravation of L-DOPAinduced neurotoxicity by tetrahydropapaveroline in PC12 cells. Biochem. Pharmacol. 66: 1787-1795. DOI ScienceOn |
16 | Saurer, H. and Oertel, W.H. (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59(2): 401-415. DOI ScienceOn |
17 | Sotelo, C., Javoy, F., Agid, T. and Glwinski, J. (1973) Injcetion of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study. Brain Res. 58: 269-290. DOI ScienceOn |
18 | Melamed, E,, Offen, D., Shirvan, A., Djaldetti, R., Barzilai, A. and Ziv, I. (1998) Levodopa toxicity and apoptosis. Ann. Neurol. 44: S149-154. |
19 | Nagatsu, T. (1997). Isoquinoline neurotoxins in the brain and Parkinson's disease, Neurosci. Res. 29: 99-111. DOI ScienceOn |
20 | Borah, A. and Mohanakumar, K.P. (2009) L-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation. Neurochem. Int. 56: 357-362. |
21 | Hatano, T., Kubo, S., Sato, S. and Hattori, N. (2009) Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease. J. Neurochem. 111: 1075-1093. DOI ScienceOn |
22 | Ziv, I., Zilkha-Falb, R., Offen, D., Shirvan, A., Barzilai, A. and Melamed, E. (1997) Levodopa induces apoptosis in cultured neuronal cells: a possible accelerator of nigrostriatal degeneration in Parkinson's disease? Mov. Disord. 12: 17-23. DOI ScienceOn |
23 | Joh, T. H., Park, D. H. and Reis, D. J. (1978) Direct phosphorylation of brain tyrosine hydroxylase by cyclic AMP dependent protein kinase: mechanism of enzyme activation. Proc. Natl. Acad. Sci. USA 75: 4744-4748. DOI ScienceOn |
24 | Young, E. A., Duchemin, A.-M., Neff, N. H. and Hadjiconstantinou, M. (1998) Parallel modulation of striatal dopamine synthetic enzymes by second messenger pathways. Eur. J. Pharmacol. 357: 15-23. DOI ScienceOn |
25 | Graham, D. G. (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14: 633-643. |
26 | Cheng, N., Maeda, T., Kume, T., Kaneko, S., Kochiyama, H., Akaike, A., Goshima, Y. and Misu, Y. (1996) Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res. 743: 278-283. DOI ScienceOn |
27 | Yacoubian, T. A. and Standaert, D. C. (2009) Targets for neuroprotection in Parkinson's disease. Biochim. Biophys. Acta 1792: 676-687. DOI ScienceOn |
28 | Bowers, W. J., Howard, D. F. and Federoff, H, J. (1997) Gene therapeutic strategies for neuroprotection: implications for Parkinson's disease. Exp. Neurol. 144: 58-68. DOI ScienceOn |
29 | Razmovski-Naumovski, V., Huang, T. H. W., Tran, V. H., Li, G. Q., Duke, C. C. and Roufogalis, B. D. (2005) Chemistry and pharmacology of Gynostemma pentaphyllum. Phytochem. Review 4: 197-210. DOI ScienceOn |
30 | Choi, H. S., Lim, S. A., Park, M. S., Hwang B. Y., Lee, C. K., Kim, S. H., Lin, S. C. and Lee, M. K. (2008) Ameliorating effects of the ethanol extracts from Gynostemma pentaphyllum on electric footshock stress. Kor. J. Pharmacogn. 39: 341-346. |
31 | Im, S. A., Choi, H. S., Hwang, B. Y., Lee, M. K. and Lee, C. K. (2009) Augmentation of immune responses by oral administration of Gynostemma pentaphyllum ethanol extract. Kor. J. Pharmacogn. 40: 35-40. |
![]() |